Monday Aug 25 | Institutional Investor
AstraZeneca Wins Prilosec Appeal
The U.S. Court of Appeals for the Federal Circuit has upheld the ruling of a District Court in favor of AstraZeneca in a patent infringement case against Apotex Corp and Impax Laboratories over its heartburn ...
Impax sued over generic painkiller
A unit of Johnson & Johnson, the world's largest maker of health-care products, sued generic drugmaker Impax Laboratories Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
Impax sued over generic prostate drug
Generic drug maker Impax Laboratories Inc. has been sued over its copy of a drug to treat prostate enlargement.
Impax sued over generic prostate drug
Generic drug maker Impax Laboratories Inc. has been sued over its copy of a drug to treat prostate enlargement.
Wyeth, Impax get court approval of Effexor patent suit settlement
Wyeth and Impax Laboratories Inc. said late Wednesday the companies' settlement of their patent infringement lawsuit related to Impax's generic version of Wyeth's Effexor XR has received court approval.
SEC revokes Impax Laboratories stock
Generic drug maker Impax Laboratories Inc. had its stock registration revoked by the Securities and Exchange Commission.
SEC revokes registration of Impax common stock
Impax Laboratories of Hayward that the SEC issued an order revoking the registration of the Company's common stock.
Public relations, press release distribution, investor relations, SEC filing
CKX, Inc. , announced today that the Special Committee of its Board of Directors is scheduled to meet on Tuesday, May 27, to consider the - 05/23/2008 - 02:31 PM HAYWARD, Calif.-- --IMPAX Laboratories, Inc.
IMPAX to Present at Citi Investment Research 2008 Global Healthcare Conference
IMPAX Laboratories, Inc. today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will present at the Citi Investment Research 2008 Global Healthcare Conference on ... via Earth Times
Read more articles in the Impax Laboratories News Archives.
For up to the minute news, check out the Impax Laboratories News Wire.
Want to add Impax Laboratories News headlines to your web site? Get the widget here.
Comment?
Impax Laboratories Poll
Top Stories
Most Popular
Recent Forum Discussions
News Trends
